Effect of an Online Reimbursement Application System on Prescribing of Lidocaine 5% Medicated Plaster in the Republic of Ireland.
Journal
Applied health economics and health policy
ISSN: 1179-1896
Titre abrégé: Appl Health Econ Health Policy
Pays: New Zealand
ID NLM: 101150314
Informations de publication
Date de publication:
01 2021
01 2021
Historique:
pubmed:
21
5
2020
medline:
26
11
2021
entrez:
21
5
2020
Statut:
ppublish
Résumé
The lidocaine 5% medicated plaster, Versatis The aim of this study was to investigate the effect of introducing a reimbursement application system on Versatis This study was carried out using prescription dispensing data from the PCRS pharmacy claims database. We carried out segmented linear regression to assess changes in the Versatis The results of the segmented regression analysis show that there was a statistically significant level (- 4.91, p < 0.001) and trend change (- 0.69, p < 0.001) in the rate of Versatis In our study, a substantial decrease in the dispensing of Versatis
Sections du résumé
BACKGROUND
The lidocaine 5% medicated plaster, Versatis
OBJECTIVE
The aim of this study was to investigate the effect of introducing a reimbursement application system on Versatis
METHODS
This study was carried out using prescription dispensing data from the PCRS pharmacy claims database. We carried out segmented linear regression to assess changes in the Versatis
RESULTS
The results of the segmented regression analysis show that there was a statistically significant level (- 4.91, p < 0.001) and trend change (- 0.69, p < 0.001) in the rate of Versatis
CONCLUSION
In our study, a substantial decrease in the dispensing of Versatis
Identifiants
pubmed: 32430656
doi: 10.1007/s40258-020-00586-5
pii: 10.1007/s40258-020-00586-5
doi:
Substances chimiques
Lidocaine
98PI200987
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
133-140Références
Medicines Management Programme. Lidocaine (versatis) prescribing and cost summary.pdf [Internet]. [cited 2019 Jul 26]. Available from: https://www.hse.ie/eng/services/publications/clinical-strategy-and-programmes/lidocaine-versatis-prescribing-cost-summary.pdf
Versatis 700 mg medicated plaster | Medicines.ie [Internet]. [cited 2019 Jul 26]. Available from: https://www.medicines.ie/medicines/versatis-700-mg-medicated-plaster-34171/
Sinnott S-J, Bennett K, Cahir C. Pharmacoepidemiology resources in Ireland—an introduction to pharmacy claims data. Eur J Clin Pharmacol. 2017;73:1449–555.
doi: 10.1007/s00228-017-2310-7
Argoff CE. Topical analgesics in the management of acute and chronic pain. Mayo Clin Proc. 2013;88:195–205.
doi: 10.1016/j.mayocp.2012.11.015
Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2163–96.
doi: 10.1016/S0140-6736(12)61729-2
Raftery MN, Sarma K, Murphy AW, De la Harpe D, Normand C, McGuire BE. Chronic pain in the Republic of Ireland—community prevalence, psychosocial profile and predictors of pain-related disability: results from the prevalence, impact and cost of chronic pain (PRIME) study, Part 1. Pain. 2011;152:1096.
doi: 10.1016/j.pain.2011.01.019
National Institute for Health and Care, Excellence. Guideline scope - Chronic pain: assessment and management [Internet]. [cited 2019 Sep 4]. Available from: https://www.nice.org.uk/guidance/gid-ng10069/documents/final-scope
Owen GT, Bruel BM, Schade CM, Eckmann MS, Hustak EC, Engle MP. Evidence-based pain medicine for primary care physicians. Proc Bayl Univ Med Cent. 2018;31:37–47.
doi: 10.1080/08998280.2017.1400290
Derry S, Wiffen PJ, Kalso EA, Bell RF, Aldington D, Phillips T, et al. Topical analgesics for acute and chronic pain in adults ‐ an overview of Cochrane Reviews. Cochrane Database Syst Rev [Internet]. 2017 [cited 2019 Sep 3];2017. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481750/
Book (eISB) electronic IS. Conditional supply of listed items. [Internet]. [cited 2019 Aug 21]. Available from: https://www.irishstatutebook.ie/eli/2013/act/14/section/20/enacted/en/html#sec20
Dayan RR, Peleg R. Herpes zoster—typical and atypical presentations. Postgrad Med. 2017;129:567–71.
doi: 10.1080/00325481.2017.1335574
Segmented regression analysis of interrupted time series studies in medication use research - Wagner - 2002 - Journal of Clinical Pharmacy and Therapeutics - Wiley Online Library [Internet]. [cited 2019 Aug 13]. Available from: https://onlinelibrary.wiley.com/doi/full/10.1046/j.1365-2710.2002.00430.x?sid=nlm%3Apubmed
Primary Care Eligibility & Reimbursement Service (PCERS) Strategic Plan 2019–2021. pp. 24.
What is the role of PCRS? [Internet]. HSE.ie. [cited 2019 Oct 2]. Available from: https://www.hse.ie/eng/staff/pcrs/about-pcrs/what-is-the-role-of-pcrs-.html
The Effect of Formulary Restrictions on Patient and Payer Outcomes: A Systematic Literature Review - PubMed [Internet]. [cited 2020 Mar 5]. Available from: https://pubmed.ncbi.nlm.nih.gov/28737993-the-effect-of-formulary-restrictions-on-patient-and-payer-outcomes-a-systematic-literature-review/
Pharmaceutical policies: effects of restrictions on reimbursement [Internet]. [cited 2020 Mar 12]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6791298/
Galer BS, Rowbotham MC, Perander J, Friedman E. Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment study. Pain. 1999;80:533–8.
doi: 10.1016/S0304-3959(98)00244-9
MRPAR - Lidocaine (Versatis) [Internet]. [cited 2019 Jul 31]. Available from: https://www.mhra.gov.uk/home/groups/par/documents/websiteresources/con2032998.pdf
Baron R, Mayoral V, Leijon G, Binder A, Steigerwald I, Serpell M. 5% lidocaine medicated plaster versus pregabalin in post-herpetic neuralgia and diabetic polyneuropathy: an open-label, non-inferiority two-stage RCT study. Curr Med Res Opin. 2009;25:1663–766.
doi: 10.1185/03007990903047880
Kesselheim AS, Myers JA, Solomon DH, Winkelmayer WC, Levin R, Avorn J. The prevalence and cost of unapproved uses of top-selling orphan drugs. PLoS ONE. 2012;7:e31894.
doi: 10.1371/journal.pone.0031894
Mc Colgan R, Dalton DM, O’Sullivan HP, Sproule JA. The prescription of lidocaine patches in osteoarthritis—a complete audit cycle. Ir J Med Sci. 2019;188:525–30.
doi: 10.1007/s11845-018-1878-y
Baron R, Allegri M, Correa-Illanes G, Hans G, Serpell M, Mick G, et al. The 5% lidocaine-medicated plaster: its inclusion in international treatment guidelines for treating localized neuropathic pain, and clinical evidence supporting its use. Pain Ther. 2016;5:149–69.
doi: 10.1007/s40122-016-0060-3
de León-Casasola OA, Mayoral V. The topical 5% lidocaine medicated plaster in localized neuropathic pain: a reappraisal of the clinical evidence. J Pain Res. 2016;9:67–79.
doi: 10.2147/JPR.S99231
Mick G, Correa-Illanes G. Topical pain management with the 5% lidocaine medicated plaster–a review. Curr Med Res Opin. 2012;28:937–51.
doi: 10.1185/03007995.2012.690339
Anand P, Dickenson A, Finco G, Marinangeli F, Polati E, Romualdi P, et al. Novel insights on the management of pain: highlights from the ‘Science of Relief’ meeting. Pain Management [Internet]. 2019 [cited 2019 Sep 4]; Available from: https://www.futuremedicine.com/doi/full/10.2217/pmt-2019-0031
Giummarra MJ, Gibson SJ, Allen AR, Pichler AS, Arnold CA. Polypharmacy and chronic pain: harm exposure is not all about the opioids. Pain Med. 2015;16:472–9.
doi: 10.1111/pme.12586
Kennedy N, O’Sullivan K, Hannigan A, Purtill H. Understanding pain among older persons: part 2—the association between pain profiles and healthcare utilisation. Age Ageing. 2017;46:51–6.
doi: 10.1093/ageing/afx144.102
Centers for Disease Control and Prevention (CDC). Vital signs: overdoses of prescription opioid pain relievers—United States, 1999–2008. MMWR Morb Mortal Wkly Rep. 2011;60:1487–92.
Compton WM, Jones CM, Baldwin GT. Relationship between nonmedical prescription-opioid use and heroin use. N Engl J Med. 2016;374:154–63.
doi: 10.1056/NEJMra1508490
Murthy VH. Ending the opioid epidemic—a call to action. N Engl J Med. 2016;375:2413–5.
doi: 10.1056/NEJMp1612578
Ebbert JO, Philpot LM, Clements CM, Lovely JK, Nicholson WT, Jenkins SM, et al. Attitudes, beliefs, practices, and concerns among clinicians prescribing opioids in a large academic institution. Pain Med. 2018;19:1790–8.
doi: 10.1093/pm/pnx140
Pharmaceutical Society of Ireland. Safe supply of Codeine to patients. [Internet]. [cited 2019 Sep 5]. Available from: https://www.thepsi.ie/Libraries/Folder_Pharmacy_Practice_Guidance/01_3_Safe_supply_of_Codeine_to_patients.sflb.ashx